ErbB3 Expression Predicts Sensitivity to Elisidepsin Treatment: In�vitro Synergism With Cisplatin, Paclitaxel and Gemcitabine in Lung, Breast and Colon Cancer Cell Lines
International Journal of Oncology - Greece
doi 10.3892/ijo.2012.1425
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2012
Authors
Publisher
Spandidos Publications